Logo image of SABE.PA

SAINT JEAN GROUPE SA (SABE.PA) Stock Fundamental Analysis

EPA:SABE - Euronext Paris - Matif - FR0000060121 - Common Stock - Currency: EUR

19.7  -0.7 (-3.43%)

Fundamental Rating

4

Overall SABE gets a fundamental rating of 4 out of 10. We evaluated SABE against 58 industry peers in the Food Products industry. SABE has an average financial health and profitability rating. While showing a medium growth rate, SABE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year SABE was profitable.
SABE had a positive operating cash flow in the past year.
SABE had positive earnings in each of the past 5 years.
In the past 5 years SABE always reported a positive cash flow from operatings.
SABE.PA Yearly Net Income VS EBIT VS OCF VS FCFSABE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M -10M

1.2 Ratios

SABE has a worse Return On Assets (2.29%) than 63.79% of its industry peers.
SABE has a Return On Equity of 5.16%. This is in the lower half of the industry: SABE underperforms 67.24% of its industry peers.
SABE's Return On Invested Capital of 2.50% is on the low side compared to the rest of the industry. SABE is outperformed by 74.14% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SABE is significantly below the industry average of 7.10%.
The last Return On Invested Capital (2.50%) for SABE is above the 3 year average (1.54%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.29%
ROE 5.16%
ROIC 2.5%
ROA(3y)1.36%
ROA(5y)1.68%
ROE(3y)3%
ROE(5y)3.26%
ROIC(3y)1.54%
ROIC(5y)1.47%
SABE.PA Yearly ROA, ROE, ROICSABE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 3.39%, SABE is in line with its industry, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Profit Margin of SABE has grown nicely.
SABE's Operating Margin of 3.68% is in line compared to the rest of the industry. SABE outperforms 41.38% of its industry peers.
SABE's Operating Margin has improved in the last couple of years.
SABE has a Gross Margin (36.62%) which is in line with its industry peers.
SABE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.68%
PM (TTM) 3.39%
GM 36.62%
OM growth 3Y38.42%
OM growth 5Y40.2%
PM growth 3Y37.41%
PM growth 5Y22.23%
GM growth 3Y-0.04%
GM growth 5Y-0.19%
SABE.PA Yearly Profit, Operating, Gross MarginsSABE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SABE is destroying value.
Compared to 1 year ago, SABE has less shares outstanding
Compared to 5 years ago, SABE has less shares outstanding
SABE has a better debt/assets ratio than last year.
SABE.PA Yearly Shares OutstandingSABE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M
SABE.PA Yearly Total Debt VS Total AssetsSABE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

SABE has an Altman-Z score of 1.96. This is not the best score and indicates that SABE is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.96, SABE is in line with its industry, outperforming 43.10% of the companies in the same industry.
SABE has a Debt/Equity ratio of 0.66. This is a neutral value indicating SABE is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.66, SABE is not doing good in the industry: 62.07% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF N/A
Altman-Z 1.96
ROIC/WACC0.42
WACC6.01%
SABE.PA Yearly LT Debt VS Equity VS FCFSABE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 1.86 indicates that SABE should not have too much problems paying its short term obligations.
The Current ratio of SABE (1.86) is better than 72.41% of its industry peers.
SABE has a Quick Ratio of 1.58. This is a normal value and indicates that SABE is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.58, SABE belongs to the best of the industry, outperforming 81.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.58
SABE.PA Yearly Current Assets VS Current LiabilitesSABE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 114.33% over the past year.
SABE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 34.81% yearly.
SABE shows a small growth in Revenue. In the last year, the Revenue has grown by 2.67%.
Measured over the past years, SABE shows a quite strong growth in Revenue. The Revenue has been growing by 9.29% on average per year.
EPS 1Y (TTM)114.33%
EPS 3Y52.1%
EPS 5Y34.81%
EPS Q2Q%-9.53%
Revenue 1Y (TTM)2.67%
Revenue growth 3Y9.01%
Revenue growth 5Y9.29%
Sales Q2Q%0.39%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SABE.PA Yearly Revenue VS EstimatesSABE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
SABE.PA Yearly EPS VS EstimatesSABE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.63, which indicates a correct valuation of SABE.
SABE's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of SABE to the average of the S&P500 Index (29.35), we can say SABE is valued slightly cheaper.
Industry RankSector Rank
PE 15.63
Fwd PE N/A
SABE.PA Price Earnings VS Forward Price EarningsSABE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SABE is valued a bit cheaper than the industry average as 68.97% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.96
SABE.PA Per share dataSABE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.45
EPS Next 2YN/A
EPS Next 3YN/A

1

5. Dividend

5.1 Amount

SABE has a yearly dividend return of 0.49%, which is pretty low.
SABE's Dividend Yield is slightly below the industry average, which is at 3.37.
Compared to an average S&P500 Dividend Yield of 2.33, SABE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.49%

5.2 History

The dividend of SABE decreases each year by -14.36%.
Dividend Growth(5Y)-14.36%
Div Incr Years0
Div Non Decr Years2
SABE.PA Yearly Dividends per shareSABE.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 0.05 0.1 0.15 0.2

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
SABE.PA Yearly Income VS Free CF VS DividendSABE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M -10M

SAINT JEAN GROUPE SA

EPA:SABE (3/7/2025, 7:00:00 PM)

19.7

-0.7 (-3.43%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners12.41%
Ins Owner ChangeN/A
Market Cap63.04M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.49%
Yearly Dividend0.1
Dividend Growth(5Y)-14.36%
DP0%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.63
Fwd PE N/A
P/S 0.54
P/FCF N/A
P/OCF 4.4
P/B 0.83
P/tB 0.9
EV/EBITDA 5.96
EPS(TTM)1.26
EY6.4%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)4.48
OCFY22.72%
SpS36.21
BVpS23.77
TBVpS21.79
PEG (NY)N/A
PEG (5Y)0.45
Profitability
Industry RankSector Rank
ROA 2.29%
ROE 5.16%
ROCE 3.13%
ROIC 2.5%
ROICexc 3.52%
ROICexgc 3.77%
OM 3.68%
PM (TTM) 3.39%
GM 36.62%
FCFM N/A
ROA(3y)1.36%
ROA(5y)1.68%
ROE(3y)3%
ROE(5y)3.26%
ROIC(3y)1.54%
ROIC(5y)1.47%
ROICexc(3y)2.29%
ROICexc(5y)2.39%
ROICexgc(3y)2.46%
ROICexgc(5y)2.63%
ROCE(3y)1.93%
ROCE(5y)1.83%
ROICexcg growth 3Y25.1%
ROICexcg growth 5Y30.92%
ROICexc growth 3Y27.18%
ROICexc growth 5Y32.95%
OM growth 3Y38.42%
OM growth 5Y40.2%
PM growth 3Y37.41%
PM growth 5Y22.23%
GM growth 3Y-0.04%
GM growth 5Y-0.19%
F-Score8
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF N/A
Debt/EBITDA 3.63
Cap/Depr 149.91%
Cap/Sales 12.48%
Interest Coverage 250
Cash Conversion 102.93%
Profit Quality N/A
Current Ratio 1.86
Quick Ratio 1.58
Altman-Z 1.96
F-Score8
WACC6.01%
ROIC/WACC0.42
Cap/Depr(3y)304.41%
Cap/Depr(5y)231.83%
Cap/Sales(3y)20.4%
Cap/Sales(5y)16.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.33%
EPS 3Y52.1%
EPS 5Y34.81%
EPS Q2Q%-9.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.67%
Revenue growth 3Y9.01%
Revenue growth 5Y9.29%
Sales Q2Q%0.39%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y85.57%
EBIT growth 3Y50.88%
EBIT growth 5Y53.22%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y99.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.96%
OCF growth 3Y24.81%
OCF growth 5Y10.92%